Kelly is a biostatistician and data scientist with more than a decade of experience in clinical trials. Prior to joining Origent, Kelly worked as a biostatistician reporting to Data Safety Monitoring Boards and providing statistical consultation for clinical trials across a range of development phases and therapeutic areas, including neurology, oncology, infectious disease, and rare disease. As a data scientist at Origent, Kelly is responsible for developing personalized predictive models for human diseases and building robust applications for their use in drug development with the goal of accelerating the discovery of new drugs and therapies.

Kelly holds a B.A. in Psychology with a minor in Biology from The University of Virginia and an M.S. in Biostatistics from The George Washington University.